Pro-Dex Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Pro-Dex Stock Forecast and Price Target
Pro-Dex's most recent price target of $27.00 for 2024 was provided by renowned analysts over the past few months, with an average prediction of $27.00. If this prediction is correct, Pro-Dex's stock could rise by 48.19 percent from its current trading price. The potential increase for the stock is $27.00 per share, with a possible range of $27.00 to $27.00. If you're not interested in PDEX stock, you may be interested in its competitors.
48.19% Upside
Pro-Dex Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Pro-Dex's Price has fallen from $18.65 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $12.68 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$240.35 | Buy/Sell | $284.47 | 15.46% |
| ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$198.73 | Buy/Sell | $263.46 | 33.35% |
| PEN Stock Forecast | Penumbra | Outperform |
9
|
$206.06 | Buy/Sell | $258.62 | 39.77% |
| GMED Stock Forecast | Globus Medical | Outperform |
16
|
$50.48 | Buy/Sell | $64.58 | 18.86% |
Pro-Dex Revenue Forecast for 2023 - 2025 - 2030
Pro-Dex's Revenue has seen impressive growth In the last three years, rising from $34.83M to $46.09M – a growth of 32.33%. In the next year, analysts believe that Revenue will reach $49.00M – an increase of 6.31%. For the next seven years, the forecast is for Revenue to grow by 5.40%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GKOS Stock Forecast | Glaukos | Outperform |
7
|
$105.03 | Buy/Sell | $87.33 | 3.78% |
| HAE Stock Forecast | Haemonetics | Outperform |
16
|
$93.33 | Buy/Sell | $70.17 | 17.86% |
| MMSI Stock Forecast | Merit Medical Systems | Outperform |
14
|
$77.02 | Buy/Sell | $89.25 | 14.91% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NARI Stock Forecast | Inari Medical | Outperform |
14
|
$41.99 | Buy/Sell | $82.67 | 41.70% |
| ICUI Stock Forecast | ICU Medical | Outperform |
16
|
$99.04 | Buy/Sell | $153.50 | 37.82% |
| NUVA Stock Forecast | NuVasive | - |
14
|
$4.86 | Buy/Sell | $73.81 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LMAT Stock Forecast | LeMaitre Vascular | Outperform |
18
|
$66.77 | Buy/Sell | $59.86 | 7.83% |
| APR Stock Forecast | Apria | - |
16
|
$37.50 | Buy/Sell | $37.50 | -100.00% |
| ATRC Stock Forecast | AtriCure | Buy |
8
|
$22.22 | Buy/Sell | $55.00 | 120.52% |
Pro-Dex EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Pro-Dex's EBITDA has gone down from $7.63M to $6.62M – a 13.24% drop. Analysts predict that Pro-Dex's EBITDA will increase in the upcoming year, reaching $9.20M. This would represent an increase of 38.97%. Over the next seven years, experts predict that Pro-Dex's EBITDA will grow at a rate of 28.48%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATRI Stock Forecast | Atrion | - |
18
|
$352.20 | Buy/Sell | $946.00 | -100.00% |
| IRMD Stock Forecast | IRadimed | Buy |
16
|
$43.85 | Buy/Sell | $60.00 | 42.53% |
| OFIX Stock Forecast | Orthofix Medical | Hold |
10
|
$13.24 | Buy/Sell | $18.00 | 13.29% |
Pro-Dex EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Pro-Dex's EBIT has fallen from $7.06M to $5.76M – a 18.41% decrease. In the next year, analysts believe that EBIT will reach $7.60M – an increase of 31.94%. For the next seven years, the forecast is forEBIT to grow by 23.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MON Stock Forecast | Misonix | - |
7
|
$26.54 | Buy/Sell | $28.00 | -100.00% |
| LYRA Stock Forecast | Lyra Therapeutics | Buy |
4
|
$4.63 | Buy/Sell | $11.80 | 137.58% |
| LUNG Stock Forecast | Pulmonx | Outperform |
4
|
$9.38 | Buy/Sell | $15.33 | 59.91% |
Pro-Dex EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Pro-Dex's EPS has fallen from $1.50 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $1.02 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SGHT Stock Forecast | Sight Sciences | Hold |
5
|
$5.61 | Buy/Sell | $3.88 | 2.50% |
| APEN Stock Forecast | Apollo Endosurgery | - |
10
|
$10.00 | Buy/Sell | $0.00 | -100.00% |
| ANGO Stock Forecast | AngioDynamics | Buy |
8
|
$6.08 | Buy/Sell | $16.33 | 113.82% |
.jpg)